UVEITIS

Clinical trials for UVEITIS explained in plain language.

Never miss a new study

Get alerted when new UVEITIS trials appear

Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New hope for kids with Arthritis-Linked eye disease?

Disease control Ongoing

This study tests an oral drug called baricitinib in children aged 2 to 18 with active uveitis linked to juvenile idiopathic arthritis or a related antibody-positive condition. The goal is to see if the drug safely reduces eye inflammation. About 30 participants will receive baric…

Matched conditions: UVEITIS

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Apr 28, 2026 22:49 UTC

UVEITIS

Get alerted when new UVEITIS trials appear

New hope for kids with Arthritis-Linked eye disease?